Daily Stock Analysis, LCI, Lannett Company Inc, priceseries

Lannett Company Inc. Daily Stock Analysis
Stock Information
Open
0.78
Close
0.77
High
0.80
Low
0.77
Previous Close
0.79
Daily Price Gain
-0.02
YTD High
1.85
YTD High Date
Jan 4, 2022
YTD Low
0.71
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.93
YTD Gain
-54.71%
52 Week High
7.28
52 Week High Date
Mar 11, 2021
52 Week Low
0.71
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-5.58
52 Week Gain
-87.88%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 5. 2017
22.00
Apr 18. 2017
24.08
8 Trading Days
9.45%
Link
LONG
Jun 21. 2017
19.25
Jul 7. 2017
20.25
11 Trading Days
5.18%
Link
LONG
Sep 26. 2017
17.70
Oct 26. 2017
22.61
22 Trading Days
27.76%
Link
LONG
Nov 21. 2017
24.55
Dec 14. 2017
28.24
16 Trading Days
15.01%
Link
LONG
Nov 1. 2018
3.98
Nov 26. 2018
5.65
16 Trading Days
42.05%
Link
LONG
Jan 3. 2019
5.59
Jan 29. 2019
7.53
17 Trading Days
34.70%
Link
LONG
Aug 29. 2019
8.88
Sep 25. 2019
11.29
18 Trading Days
27.14%
Link
LONG
Oct 2. 2020
6.13
Oct 26. 2020
6.78
16 Trading Days
10.66%
Link
LONG
Jan 25. 2021
7.93
Jan 28. 2021
8.36
3 Trading Days
5.39%
Link
Company Information
Stock Symbol
LCI
Exchange
NYSE
Company URL
http://www.lannett.com
Company Phone
2153339000
CEO
Arthur P. Bedrosian
Headquarters
Pennsylvania
Business Address
9000 STATE RD, PHILADELPHIA, PA 19136
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0000057725
About

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.

Description

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. It offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. The company provides its products for various medical indications comprising glaucoma, muscle relaxant, migraine, anesthetic, congestive heart failure, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, dryness of the mouth, gout, hypertension, and gallstone. It also manufactures active pharmaceutical ingredients. Lannett Company, Inc. markets its products under the Diamox, Fioricet, Fiorinal, Lanoxin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Salagen, Dyazide, and Actigall brands. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.